Expert advisers urge FDA to pull pregnancy drug from market - 1breakingnews.com

1BN 2022-10-20

Views 4

The panel rejected arguments that Makena should remain available for high-risk groups, including some Black women.

VIEW MORE : https://bit.ly/1breakingnews
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
FDA advisers recommend approval of controversial ALS drug - 1breakingnews.com
play
00:23

FDA advisers recommend approval of controversial ALS drug - 1breakingnews.com
FDA yanks approval of Makena, only drug cleared to lower preterm birth - 1breakingnews.com
play
00:23

FDA yanks approval of Makena, only drug cleared to lower preterm birth - 1breakingnews.com
FDA Advisers Recommend Anti-Opioid Overdose Drug for OTC Use
play
01:30

FDA Advisers Recommend Anti-Opioid Overdose Drug for OTC Use
U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people
play
01:18

U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people
FDA Postpones Meeting With Expert Advisers on Pfizer’s Vaccine for Young Kids
play
01:30

FDA Postpones Meeting With Expert Advisers on Pfizer’s Vaccine for Young Kids
FDA advisers endorse Moderna's COVID-19 vaccine
play
01:56

FDA advisers endorse Moderna's COVID-19 vaccine
FDA advisers endorse Moderna's COVID-19 vaccine
play
01:56

FDA advisers endorse Moderna's COVID-19 vaccine
FDA Advisers Narrowly Endorse Merck’s COVID Antiviral Pill
play
01:30

FDA Advisers Narrowly Endorse Merck’s COVID Antiviral Pill
FDA Advisers Recommend Booster of Johnson & Johnson's COVID-19 Vaccine
play
02:24

FDA Advisers Recommend Booster of Johnson & Johnson's COVID-19 Vaccine
FDA advisers endorse Moderna's COVID-19 vaccine
play
01:56

FDA advisers endorse Moderna's COVID-19 vaccine
FDA Advisers Recommend Omicron-Focused COVID Boosters for Fall
play
00:46

FDA Advisers Recommend Omicron-Focused COVID Boosters for Fall
FDA advisers endorse Moderna's COVID-19 vaccine
play
01:56

FDA advisers endorse Moderna's COVID-19 vaccine